EPSTEIN-BARR-VIRUS (EBV) IN LYMPHOIDEN ZELLEN - EIN HUMANES VIRUS. = VIRUS D'EPSTEIN-BARR DANS LES CELLULES LYMPHOIDES, UN VIRUS TUMORAL HUMAIN.DIEHL V.1977; MED. WELT; DTSCH.; DA. 1977; VOL. 28; NO 15; PP. 737-745; BIBL. 66 REF.Article

ESTABLISHMENT OF PERIPHERAL LYMPHOID CELL CULTURES FROM PATIENTS WITH HODGKIN'S DISEASE DEPENDING ON EPSTEIN-BARR-VIRUS-REACTIVITY AND CELLULAR IMMUNITY.DIEHL V; JOHANSSON B.1977; BLUT; DTSCH.; DA. 1977; VOL. 34; NO 3; PP. 227-236; ABS. ALLEM.; BIBL. 1 P. 1/2Article

Future strategy for cancer treatment using recombinant human granulocyte colony stimulating factorDIEHL, V.European journal of cancer. Part A. 1994, Vol 30, pp S44-S47, SUP3Conference Paper

Fractionated chemotherapy : granisetron or conventional antiemetics ?DIEHL, V.European journal of cancer. Part A. 1992, Vol 28, pp S21-S28, SUP1Conference Paper

Dose-escalation study for the treatment of Hodgkin's diseaseDIEHL, V.Annals of hematology (Print). 1993, Vol 66, Num 3, pp 139-140, issn 0939-5555Conference Paper

AENDERUNG DER PHARMAKOKINETIK VON METHOTREXAT DURCH EINSCHLUSS IN LIPOSOMEN UND DIE UNTERSCHIEDLICHE WIRKUNG AUF EXPERIMENTELL INDUZIERTE TUMOREN = MODIFICATION DE LA PHARMACOCINETIQUE DU METHOTREXATE PAR INCLUSION DANS LES LIPOSOMES ET LES EFFETS SUR LES TUMEURS EXPERIMENTALESFREISE J; DIEHL V.1981; ONKOLOGIE; ISSN 0378-584X; CHE; DA. 1981; VOL. 4; NO 1; PP. 4-5; ABS. ENG; BIBL. 6 REF.Article

NEUE REAKTIONEN IN DER ISATIN-REIHE. II. DAS 2-HYDROXY-1.4-DIHYDRO-CHINOLIN-SYSTEM = NOUVELLES REACTIONS DANS LA SERIE DE L'ISATINE. II. LE SYSTEME HYDROXY-2 DIHYDRO-1,4 QUINOLEINECAPUANO L; DIEHL V; EBNER W et al.1972; CHEM. BER.; DTSCH.; DA. 1972; VOL. 105; NO 10; PP. 3407-3412; ABS. ANGL.; BIBL. DISSEM.Serial Issue

PROLIFERATION KINETICS OF MALIGNANT NON-HODGKIN'S LYMPHOMAS RELATED TO HISTOPATHOLOGY OF LYMPH NODE BIOPSIESLANG W; KIENZLE S; DIEHL V et al.1980; VIRCHOWS ARCH., A; ISSN 0340-1227; DEU; DA. 1980; VOL. 389; NO 3; PP. 397-407; BIBL. 3 P.Article

ROENTGENOLOGISCHE BEOBACHTUNGEN DER AUSBREITUNG MALIGNER LYMPHO-RETIKULAERER PROZESSE IM LUNGENPARENCHYM UND DES VERHALTENS UNTER ZYTOSTALISCHER THERAPIE = SURVEILLANCES RADIOLOGIQUES DE L'EXTENSION DES PROCESSUS LYMPHORETICULAIRES MALINS DANS LE PARENCHYME PULMONAIRE, ET DE LEUR STABILISATION SOUS THERAPEUTIQUE CYTOSTATIQUELUSKA G; DIEHL V; RHOMBERG W et al.1975; ROENTG.-BL.; DTSCH.; DA. 1975; VOL. 28; NO 11; PP. 537-546; ABS. ANGL.; BIBL. 16 REF.Article

International Symposium on Hodgkin's LymphomaDIEHL, V; ENGERT, A.Annals of oncology. 1996, Vol 7, issn 0923-7534, 150 p., SUP4Conference Proceedings

Controversies in the management of non-Hodgkin lymphomaENGERT, A; DIEHL, V.European journal of cancer (1990). 1991, Vol 27, Num 3, pp 309-315, issn 0959-8049Conference Paper

MOLECULAR CLONING AND CHARACTERIZATION OF HUMAN PAPILLOMA VIRUS DNA DERIVED FROM A LARYNGEAL PAPILLOMA = CLONAGE MOLECULAIRE ET CARACTERISATION D'UN ADN DE VIRUS DE PAPILLOME HUMAIN OBTENU A PARTIR D'UN PAPILLOME LARYNGEGISSMANN L; DIEHL V; SCHULTZ COULON HJ et al.1982; J. VIROL.; ISSN 0022-538X; USA; DA. 1982; VOL. 44; NO 1; PP. 393-400; BIBL. 32 REF.Article

RE-EXPOSURE OF HUMAN LYMPHOBLASTOID CELL LINES TO EPSTEIN-BARR VIRUSDIEHL V; WOLF H; SCHULTE HOLTHAUSEN H et al.1972; INTERNATION. J. CANCER; SWITZ; DA. 1972; VOL. 10; NO 3; PP. 641-651; ABS. FR.; BIBL. 1P.Serial Issue

A POSSIBLE CORRELATION BETWEEN THE DEGREE OF KARYOTYPE ABERRATIONS AND THE RATE OF SISTER CHROMATID EXCHANGES IN LYMPHOMA LINESFONATSCH C; SCHAADT M; KIRCHNER H et al.1980; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1980; VOL. 26; NO 6; PP. 749-756; BIBL. 27 REF.Article

INTRACRANIAL HETEROTRANSPLANTATION OF HUMAN HEMATOPOIETIC CELLS IN NUDE MICESCHAADT M; KIRCHNER H; FONATSCH C et al.1979; INTERNATION. J. CANCER; CHE; DA. 1979; VOL. 23; NO 6; PP. 751-761; ABS. FRE; BIBL. 2 P.Article

Efficacy and safety of antiemeticsDIEHL, V; MARTY, M.Cancer treatment reviews. 1994, Vol 20, Num 4, pp 379-392, issn 0305-7372Article

Position reversal: isolating the key factor in assimilation and contrastHART, B; DIEHL, V. A.The Journal of psychology. 1994, Vol 128, Num 1, pp 71-87, issn 0022-3980Article

TRANSLOCATION T (8;22) IN PERIPHERAL LYMPHOCYTES AND ESTABLISHED LYMPHOID CELL LINES FROM A PATIENT WITH HODGKINS DISEASE FOLLOWED BY ACUTE LYMPHATIC LEUKEMIAFONATSCH C; BURRICHTER H; SCHAADT M et al.1982; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1982; VOL. 30; NO 3; PP. 321-327; BIBL. 2 P.Article

DETERMINATION OF METHOTREXATE IN SERUM BY A RAPID, FULLY MECHANIZED ENZYME IMMUNOASSAY (EMIT)OELLERICH M; ENGELHARDT P; SCHAADT M et al.1980; J. CLIN. CHEM. CLIN. BIOCHEM.; DEU; DA. 1980; VOL. 18; NO 3; PP. 169-174; ABS. GER; BIBL. 32 REF.Article

TWO NEOPLASTIC CELL LINES WITH UNIQUE FEATURES DERIVED FROM HODGKIN'S DISEASESCHAADT M; DIEHL V; STEIN H et al.1980; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1980; VOL. 26; NO 6; PP. 723-731; BIBL. 2 P.Article

LANGZEITAUSWIRKUNGEN DER SPLENEKTOMIE AUF DEN IMMUNSTATUS VON HODGKIN-PATIENTEN IN ABHAENGIGKEIT VON DER THERAPIEFORM = EFFETS A LONG TERME DE LA SPLENECTOMIE SUR LE STATUT IMMUNOLOGIQUE SUR LES PATIENTS ATTEINTS D'UNE MALADIE DE HODGKIN COMPTE TENU DU PROTOCOLE DE TRAITEMENTSCHAADT M; DIEHL V; KALDEN JR et al.1978; MED. KLIN.; DEU; DA. 1978; VOL. 73; NO 40; PP. 1381-1388; ABS. ENG; BIBL. 30 REF.Article

HUMORAL AND CELLULAR IMMUNE REACTIONS IN VITRO AGAINST ALLOGENEIC AND AUTOLOGOUS HUMAN MELANOMA CELLSPETER HH; KALDEN JR; SEELAND P et al.1975; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1975; VOL. 20; NO 2; PP. 193-207; BIBL. 2P.Article

RELATION BETWEEN CELLULAR IMMUNITY TO NEPHROBLASTOMA AND THE PHASE OF THE DISEASE = RELATION ENTRE L'IMMUNITE CELLULAIRE AU NEPHROBLASTOME ET LE STADE DE LA MALADIEJEREB B; DIEHL V; AHSTROEM L et al.1972; ACTA PAEDIATR. SCAND.; SUEDE; DA. 1972; VOL. 61; NO 6; PP. 709-714; BIBL. 6REF.Serial Issue

Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's diseaseHASENCLEVER, D; LOEFFLER, M; DIEHL, V et al.Annals of oncology. 1996, Vol 7, pp 95-98, issn 0923-7534, SUP4Conference Paper

Current clinical trials in Hodgkin's diseaseREUSS, K; ENGERT, A; TESCH, H et al.Annals of oncology. 1996, Vol 7, pp 109-114, issn 0923-7534, 5 p., SUP4Conference Paper